Clin2
NCT03869814Possibly a fitRecruiting

Blood test to study cancer signals without invasive procedures

Diagnosis of Cancer of Various Organs

Treatments studied

Part of Cancer clinical trials.

This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20,000 people
Ages
21 years to 80 years
Study type
Observational

Who can take part

  • Be age 21 to 80 when you enroll
  • Be able to fully consent to the study
  • Have a known cancer diagnosis or a high suspicion of cancer
  • Have never had cancer before (except some non-melanoma skin cancers treated more than 1 year ago)
  • Have not had cancer treatment or cancer-related medications before enrollment
  • Not have had certain recent medical events (general anesthesia for surgery in the last 2 months, dialysis, recent blood transfusion, or pregnancy in the last 12 months)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07046260Recruiting
Blood test study for early cancer detection

This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.

Coronado, California
NCT05181826Recruiting
Blood collection study for cancer and benign diseases

This study collects blood samples from people with different health conditions (cancer, diabetes, liver disease, etc.) and from healthy volunteers. The goal is to find markers in the blood that could help detect or monitor diseases.

Redondo Beach, California
NCT05366881Recruiting
Blood test study to spot early cancer signal and cancer leftovers

This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.

Duarte, California
NCT05088395Recruiting
Blood tests to track cancer signals after treatment

This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.

Paris
NCT06790355Not yet recruiting
Blood test for early cancer detection in healthy adults

This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.

NCT06851975Recruiting
Blood tests to learn about cancer and treatment

This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.

Nice

Hear when a new Diagnosis of Cancer of Various Organs trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.